Author Correction: Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study
Crossref DOI link: https://doi.org/10.1007/s13300-018-0423-3
Published Online: 2018-04-10
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ciresi, Alessandro
Vigneri, Enrica
Radellini, Stefano
Pantò, Felicia
Giordano, Carla http://orcid.org/0000-0003-1731-9395
Article History
First Online: 10 April 2018